Analyses and presentations

Corporate Presentation

Corporate presentation September 2025

Analyses

• 11 Sep 2025 / Redeye Initiation of Coverage September 11, 2025
  https://guardtherapeutics.com/assets/uploads/Redeye-Initiation-of-Coverage-250911.pdf
• 25 Aug 2025 / Carnegie Access 22 August, 2025
  https://guardtherapeutics.com/assets/uploads/Carnegie_250822.pdf
• 14 May 2025 / Carnegie Access 14 May, 2025
  https://guardtherapeutics.com/assets/uploads/Carnegie_250514.pdf
• 08 Apr 2025 / Carnegie Access 8 April, 2025
  https://guardtherapeutics.com/assets/uploads/Carnegie_250408.pdf
• 17 Mar 2025 / Carnegie Access news flash 14 March 2025
  https://guardtherapeutics.com/assets/uploads/Carnegie_250314-news-flash.pdf
• 18 Feb 2025 / Carnegie Access 17 February 2025
  https://guardtherapeutics.com/assets/uploads/Carnegie_250217.pdf

Presentations & interviews

• 17 Oct 2024 / Guard presents at Redeye Theme "Cardiovascular & Metabolic Diseases Event 2024"
  https://www.redeye.se/videoiframe/1044029
• 23 Sep 2024 / CEO Tobias Agervald appears on BiotechTV
  https://www.biotechtv.com/post/guard-therapeutics-september-21-2024
• 19 Sep 2024 / Presentation at Pareto Securities' 15th Annual Healthcare Conference
  https://guardtherapeutics.com/assets/uploads/Guard-Tx-Pareto-19Sept2024-final.pdf
• 30 Jan 2024 / Guard Therapeutics R&D update January 30, 2024
  https://youtube.com/live/Enob5jUFw8I
• 23 Nov 2023 / Tobias Agervald presents at ABGSC Investor Days
  https://www.youtube.com/watch?v=e2-bDLGMznk&list=PLgLifPc-PiGOhe-TjD_5jry8sc-EVJAoK&index=38
• 19 Sep 2023 / Presentation from Investor Webcast - AKITA Top-line results
  https://guardtherapeutics.com/assets/uploads/Webcast-presentation-top-line-results_19-Sept-2023.pdf